JPRN-jRCT2080221584未知1 期
Phase I Clinical Trial of TO-203 - Safety Trial in Patients with HDM (House Dust Mite)-induced Asthma
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 49age old（—）
- 性别
- Male
入选标准
- •1) Positive specific IgE against HDM (>=IgE Class 3)
- •2) Positive HDM-allergen scratch test
排除标准
- •1) A clinical history of perennial allergic asthma and/or rhinitis caused by an allergen to which the patient is regularly exposed, and sensitised (except HDM)
- •2) Previous treatment by immunotherapy with HDM
研究者
相似试验
未知
1 期
Phase I clinical trial of TO-206 - Safety trial in patients with Japanese cedar pollinosisJapanese cedar pollinosisJPRN-jRCT2080222215TORII PHARMACEUTICAL CO., LTD.70
尚未招募
不适用
A phase I clinical trial to study the safety of treatment with Tipifarnib (ZARNESTRA) combined with Bortezomib (VELCADE) in patients with myelodysplastic syndrome (MDS)myelodysplasiamyelodysplastic syndroom10018865NL-OMON30154niversitair Medisch Centrum Sint Radboud18
已完成
1 期
Mesenchymal Stem Cells Transplantation in newly diagnosed Type-1 Diabetes PatientsDiabetes.Insulin-dependent diabetes mellitusIRCT2016070428786N1Royan Institute20
已完成
不适用
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted with MPLA Liposomes, in Healthy, HIV-Uninfected AdultsNL-OMON48531Academisch Medisch Centrum24
终止
1 期
A first-in-human study of VG161 in participants with advanced malignant tumours that have not responded to conventional therapies.Advanced malignant solid tumorsCancer - Other cancer typesCancer - Any cancerACTRN12620000244909Virogin Biotech Australia Pty. Ltd.7